PRX003 is a monoclonal antibody under development by Prothena for the possible treatment of inflammatory diseases. It is currently being tested in patients with multiple sclerosis (MS).

Immune cells release cytokines that can trigger inflammation and are central to many inflammatory diseases. An MCAM (melanoma cell adhesion molecule) binds to a partner molecule the blood stream then then allows it to infiltrate adjacent tissues, leading to inflammation.

In healthy people, the blood-brain barrier prevents immune cells (lymphocytes) from entering the central nervous system. In people with MS, two types of lymphocytes, CD4 and CD8, find a way to cross the barrier. They then destroy the myelin sheath that protects neurons, resulting in brain lesions.

MCAM may play a crucial role in MS because it is necessary for the migration of both CD4 and CD8 lymphocytes across the blood-brain barrier. Blocking MCAM may delay the onset of MS and significantly slow its progression.

PRX003 binds to MCAM, blocks the route of inflammation, and prevents the migration of CD4 and CD8 lymphocytes into the brain tissue.

In March, Prothena completed a single ascending dose study of PRX003 in healthy participants (NCT02458677). All doses of PRX003 were reported as safe and tolerated following a single infusion up to 30 mg/kg dose. The results showed that PRX003 administration led to more than 95 percent MCAM neutralization.

Adverse effects reported were headache, balance disorder, seasonal allergies, and viral upper respiratory tract infection in 5 percent of participants.

A Phase 1b clinical study of PRX003 in people with psoriasis (NCT02630901) is ongoing.

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

After a Full Dose of Steroids, I’m Still a Little Old Man at 63

“Let’s go for a walk,” my wife, Jane, chirpily suggested. This was a bit of a nightmare. I had to put on trousers. I perhaps cheekily get away with only wearing an apron all day. It makes going to the bathroom so much easier. (A little later in the day I spent an hour proving […]

#ACTRIMS2021 – Young Brain Fluid (CSF) Rejuvenates Memory in Mice

Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25-27. Go here to see all the latest stories from the conference. Factors in the cerebrospinal fluid (CSF) surrounding the brain and spinal cord change with age and can affect memory and the activity of myelin-producing […]

#ACTRIMS2021 – 30 Minutes in Sun Each Day Lowers MS Risk in Children

Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. Spending more time in the summer sun and living in generally sunnier places appears to provide protection against pediatric-onset multiple sclerosis (MS), an international […]

The Disturbing Trend of Caregiver Abuse in the MS Community

This is disturbing and, unfortunately, not surprising. More than 50% of people with advanced multiple sclerosis reported they’ve been mistreated by a family member or friend who cares for them, according to the results of a survey published last September by researchers at the University of California, Riverside. Much of that mistreatment (44.2%) was described […]

#ACTRIMS2021 – Research Examines T-cells’ Anti-inflammatory Potential

Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Regulatory immune cells expressing the melanoma cell adhesion molecule (MCAM) dampen inflammation at sites of nerve damage in multiple sclerosis (MS), making them a potential […]

#ACTRIMS2021 – Blood NFL Levels Seen to Rise With Markers of MS Progression

Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. Higher blood levels of neurofilament light chain (sNfL) were linked with disability, brain atrophy, and other features of multiple sclerosis (MS) in an ongoing […]

#ACTRIMS2021 – Better Strategies Needed to Help Socioeconomically Disadvantaged Patients

Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25-27. Go here to see all the latest stories from the conference. People with multiple sclerosis (MS) who are less socioeconomically advantaged tend to have faster rates of nervous system damage, new research suggests. […]

Coming Soon: 31 Days of MS

Multiple Sclerosis News Today is excited to announce a new initiative called “31 Days of MS,” in recognition of Multiple Sclerosis Awareness Month in March. We will feature a range of stories from people in the MS community, from patients to caregivers to family members.  The goal of this project is to feature a member […]

MS in Harmony is First Digital Music Therapy for MS Patients

Bristol Myers Squibb (BMS) and the American Music Therapy Association (AMTA) are partnering with singer and actor Ben Platt, and dancer, choreographer and actor Courtney Platt, to launch MS in Harmony, the first digital music therapy for patients with multiple sclerosis (MS). “We’re thrilled to have the chance to share music therapy with the MS community […]